Noncoding RNAs emerging as novel biomarkers in pancreatic cancer

Ingrid Garajová, Rita Balsano, Chiara Tommasi, Elisa Giovannetti

Research output: Contribution to journalReview articleAcademicpeer-review

Abstract

Noncoding RNAs play important regulatory roles in diverse biological processes and their misregula-tion might lead to different diseases, including cancer. Previous studies have reported the evolving role of miR-NAs as new potential biomarkers in cancer diagnosis, prognosis, as well as predictive biomarkers of chemotherapy response or therapeutic targets. In this review, we outline the involvement of noncoding RNA in pancreatic cancer, providing an overview of known miRNAs in its diagnosis, prognosis and chemoresistance. In addition, we discuss the influence of non-coding RNAs in the metastatic behavior of pancreatic cancer, as well as the role of diet in epigenetic regulation of non-coding RNAs in cancer, which can, in turn, lead the development of new prevention’s techniques or novel targets for cancer therapy.
Original languageEnglish
Pages (from-to)4601-4604
JournalCurrent pharmaceutical design
Volume24
Issue number39
DOIs
Publication statusPublished - 2018

Cite this

Garajová, Ingrid ; Balsano, Rita ; Tommasi, Chiara ; Giovannetti, Elisa. / Noncoding RNAs emerging as novel biomarkers in pancreatic cancer. In: Current pharmaceutical design. 2018 ; Vol. 24, No. 39. pp. 4601-4604.
@article{37630d1a240b4842bf4dc188f1a13789,
title = "Noncoding RNAs emerging as novel biomarkers in pancreatic cancer",
abstract = "Noncoding RNAs play important regulatory roles in diverse biological processes and their misregula-tion might lead to different diseases, including cancer. Previous studies have reported the evolving role of miR-NAs as new potential biomarkers in cancer diagnosis, prognosis, as well as predictive biomarkers of chemotherapy response or therapeutic targets. In this review, we outline the involvement of noncoding RNA in pancreatic cancer, providing an overview of known miRNAs in its diagnosis, prognosis and chemoresistance. In addition, we discuss the influence of non-coding RNAs in the metastatic behavior of pancreatic cancer, as well as the role of diet in epigenetic regulation of non-coding RNAs in cancer, which can, in turn, lead the development of new prevention’s techniques or novel targets for cancer therapy.",
author = "Ingrid Garajov{\'a} and Rita Balsano and Chiara Tommasi and Elisa Giovannetti",
year = "2018",
doi = "10.2174/1381612825666190119125804",
language = "English",
volume = "24",
pages = "4601--4604",
journal = "Current pharmaceutical design",
issn = "1381-6128",
number = "39",

}

Noncoding RNAs emerging as novel biomarkers in pancreatic cancer. / Garajová, Ingrid; Balsano, Rita; Tommasi, Chiara; Giovannetti, Elisa.

In: Current pharmaceutical design, Vol. 24, No. 39, 2018, p. 4601-4604.

Research output: Contribution to journalReview articleAcademicpeer-review

TY - JOUR

T1 - Noncoding RNAs emerging as novel biomarkers in pancreatic cancer

AU - Garajová, Ingrid

AU - Balsano, Rita

AU - Tommasi, Chiara

AU - Giovannetti, Elisa

PY - 2018

Y1 - 2018

N2 - Noncoding RNAs play important regulatory roles in diverse biological processes and their misregula-tion might lead to different diseases, including cancer. Previous studies have reported the evolving role of miR-NAs as new potential biomarkers in cancer diagnosis, prognosis, as well as predictive biomarkers of chemotherapy response or therapeutic targets. In this review, we outline the involvement of noncoding RNA in pancreatic cancer, providing an overview of known miRNAs in its diagnosis, prognosis and chemoresistance. In addition, we discuss the influence of non-coding RNAs in the metastatic behavior of pancreatic cancer, as well as the role of diet in epigenetic regulation of non-coding RNAs in cancer, which can, in turn, lead the development of new prevention’s techniques or novel targets for cancer therapy.

AB - Noncoding RNAs play important regulatory roles in diverse biological processes and their misregula-tion might lead to different diseases, including cancer. Previous studies have reported the evolving role of miR-NAs as new potential biomarkers in cancer diagnosis, prognosis, as well as predictive biomarkers of chemotherapy response or therapeutic targets. In this review, we outline the involvement of noncoding RNA in pancreatic cancer, providing an overview of known miRNAs in its diagnosis, prognosis and chemoresistance. In addition, we discuss the influence of non-coding RNAs in the metastatic behavior of pancreatic cancer, as well as the role of diet in epigenetic regulation of non-coding RNAs in cancer, which can, in turn, lead the development of new prevention’s techniques or novel targets for cancer therapy.

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85063965985&origin=inward

UR - https://www.ncbi.nlm.nih.gov/pubmed/30659532

U2 - 10.2174/1381612825666190119125804

DO - 10.2174/1381612825666190119125804

M3 - Review article

VL - 24

SP - 4601

EP - 4604

JO - Current pharmaceutical design

JF - Current pharmaceutical design

SN - 1381-6128

IS - 39

ER -